XiaoMi-AI文件搜索系统
World File Search SystemHuisheng
回生口服液治疗肺癌作用机制的网络药理学分析
临床上，中医药主要用于辅助放化疗、靶向治疗、姑息治疗等一线治疗方案。回生口服液由化证回生丹改良而成，是《温病条辨》中广泛用于肿瘤治疗的经典中药方剂。近年来，许多临床试验研究了回生口服液对肺癌患者改善免疫功能和抑制肿瘤血管生成的影响（1,2），结果发现回生口服液可以增强患者免疫功能，抑制肿瘤血管生成和肿瘤细胞增殖，改善患者生活质量，增强疗效，降低联合化疗的毒性。但回生口服液对肺癌的作用机制尚不明确。
Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.（“公司”或“ Sihuan Pharmaceutical”的董事会（“董事会”）及其子公司“组”）很高兴地宣布，胰岛素阿斯帕特的胰岛素注射，胰岛素ASPART 30 ASPART 30 ASPART BI BIBIARICE BI BI BI BIBAICERICE YESPART BI BI BI BIBARE SEDICATION由Huutarace开发了Huutarace。该集团的非全方位子公司Huisheng Biopharmaceutical”）获得了中华人民共和国国家医疗产品管理局（“ NMPA”）的药物注册批准（“中国”），以治疗糖尿病。作为批准Huisheng Biopharmaceutical营销的第一批胰岛素产品，它是Huisheng Biopharmaceutical的新里程碑，可以正式从研究和开发阶段正式转移到其在糖尿病和并发症领域的全部产品的商业化阶段。
自愿公告接受新药...
Sihuan Pharmaceutical Holdings Group Ltd.（“公司”或“ Sihuan Pharmaceutical”的董事会（“董事会”）及其子公司“ Group”）很高兴地宣布，Proline Janagliflozin Tablets（商业名称：HuiiyOujing（Huiiyoujing）（huiyOujing），“ sod®）由Huisheng Biopharmaceutical Co.，Ltd。（“ Huisheng Biopharmaceutical”）开发的抑制剂（“ SGLT-2抑制剂”）和全国1级创新药物，该集团的非全方位子公司是该集团的非全国子公司，已从国家医疗产品管理（NAME MEAFTARY PRODUCTION ADMINDISTION（“ NMPAPA”）中获得了药物注册批准， 糖尿病。这将是在中国批准和销售的第二个自我开发的SGLT-2抑制剂创新药物，这标志着Huisheng Biopharmaceutical在糖尿病治疗领域创新药物的研究和开发中的突破。
自愿公告有关Mash产品“ Lanifibranor”和“ TQA2225”的开发进度的最新消息
Huisheng Biopharmaceutical是Sihuan Pharmaceutical的生物制药公司，这是一个大型的国内药物和医学美学群体，重点是糖尿病和并发症的领域。经过十年的建设和开发，Huisheng Biopharmaceutical已成为中国为数不多的糖尿病和相关并发症领域全面产品覆盖的公司之一，并整合了整个研发，生产和销售的工业连锁店。该公司目前拥有一支世界一流的研发团队，在糖尿病药物研发方面具有丰富的经验。目前，它在糖尿病和并发症的研究产品管道中拥有40多种产品，涵盖了一系列的第二，第三和新一代胰岛素（涵盖基本，预混合和快速效果等。），具有最新机制的创新药物，例如SGLT-2抑制剂，GLP-1激动剂以及其他降血糖药物和并发症药物。Huisheng Biopharmaceutical致力于为糖尿病患者提供完整的，全面的综合治疗解决方案，为患者提供服务并使健康更加容易。
Sihuan Pharmaceutical Holdings Group Ltd.
胰岛素degludec是新一代长效的基础胰岛素类似物和B类药物，在国家报销药物清单下。具有独特的分子结构和长作用机制，具有出色的降血糖作用，对血糖浓度的稳定控制，持久效应，低血糖症的低风险和高安全性。胰岛素degludec的半衰期长达25小时，作用持续时间约为42小时，这比胰岛素甘gargine明显好。这是第一个允许糖尿病患者在一天中的任何时间（相隔8小时）注射的长效胰岛素。注射时间更灵活，患者的依从性更高。此外，使用胰岛素Degludec的2型糖尿病患者低血糖的风险大大降低，尤其是与胰岛素glargine相比，晚上严重低血糖症的发生率显着降低了53％。III期临床研究数据表明，Huisheng Biopharmaceutical开发的Huiyouda的临床疗效和安全性与原始药物Tresiba®相似。
老年急性髓系白血病微移植专家共识 - 国际微移植兴趣小组报告
Recommended Citation Recommended Citation Ai, Huisheng; Chao, Nelson J; Rizzieri, David A; Huang, Xiaojun; Spitzer, Thomas R; Wang, Jianxiang; Guo, Mei; Keating, Armand; Krakow, Elizabeth F; Blaise, Didier; Ma, Jun; Wu, Depei; Reagan, John; Gergis, Usama; Duarte, Rafael F; Chaudhary, Preet M; Hu, Kaixun; Yu, Changlin; Sun, Qiyun; Fuchs, Ephraim; Cai, Bo; Huang, Yajing; Qiao, Jianhui; Gottlieb, David; Schultz, Kirk R; Liu, Mingyao; Chen, Xiequn; Chen, Wenming; Wang, Jianmin; Zhang, Xiaohui; Li, Jianyong; Huang, He; Sun, Zimin; Li, Fei; Yang, Linhua; Zhang, Liansheng; Li, Lijuan; Liu, Kaiyan; Jin, Jie; Liu, Qifa; Liu, Daihong; Gao, Chunji; Fan, Chuanbo; Wei, Li; Zhang, Xi; Hu, Liangding; Zhang, Weijing; Tian, Yuyang; Han, Weidong; Zhu, Jun; Xiao, Zhijian; Zhou, Daobin; Zhang, Bolong; Jia, Yongqian; Zhang, Yongqing; Wu, Xiaoxiong; Shen, Xuliang; Lu, Xuzhang; Zhan, Xinrong; Sun, Xiuli; Xiao, Yi; Wang, Jingbo; Shi, Xiaodong; Zheng, Bo; Chen, Jieping; Ding, Banghe; Wang, Zhao; Zhou, Fan; Zhang, Mei; Zhang, Yizhuo; Sun, Jie; Xia, Bing; Chen, Baoan; and Ma, Liangming, "Expert Consensus on Microtransplant for Acute Myeloid Leukemia in Elderly Patients -Report From the International Microtransplant Interest Group" (2023). Department of Medical Oncology Faculty Papers. Paper 233. https://jdc.jefferson.edu/medoncfp/233
柔性传感器技术路线图
Yifei Luo, Mohammad Reza Abidian, Jong-Hyun Ahn, Deji Akinwande, Anne M. Andrews, Markus Antonietti, Zhenan Bao, Magnus Berggren, Christopher A. Berkey, Christopher John Bettinger, Jun Chen, Peng Chen, Wenlong Cheng, Xu Cheng, Seon-Jin Choi, Alex Chortos, Canan Dagdeviren, Reinhold H. Dauskardt, Chong-an Di, Michael D. Dickey, Xiangfeng Duan, Antonio Facchetti, Zhiyong Fan, Yin Fang, Jianyou Feng, Xue Feng, Huajian Gao, Wei Gao, Xiwen Gong, Chuan Fei Guo, Xiaojun Guo, Martin C. Hartel, Zihan He, John S. Ho, Youfan Hu, Qiyao Huang, Yu Huang, Fengwei Huo, Muhammad M. Hussain, Ali Javey, Unyong Jeong, Chen Jiang, Xingyu Jiang, Jiheong Kang, Daniil Karnaushenko, Ali Khademhosseini, Dae-Hyeong Kim, Il-Doo Kim, Dmitry Kireev, Lingxuan Kong, Chengkuo Lee, Nae-Eung Lee, Pooi See Lee, Tae-Woo Lee, Fengyu Li, Jinxing Li, Cuiyuan Liang, Chwee Teck Lim, Yuanjing Lin, Darren J. Lipomi, Jia Liu, Kai Liu, Nan Liu, Ren Liu, Yuxin Liu, Yuxuan Liu, Zhiyuan Liu, Zhuangjian Liu, Xian Jun Loh, Nanshu Lu, Zhisheng Lv, Shlomo Magdassi, George G. Malliaras, Naoji Matsuhisa, Arokia Nathan, Simiao Niu, Jieming Pan, Changhyun Pang, Qibing Pei, Huisheng Peng, Dianpeng Qi, Huaying Ren, John A. Rogers, Aaron Rowe, Oliver G. Schmidt, Tsuyoshi Sekitani, Dae-Gyo Seo, Guozhen Shen, Xing Sheng, Qiongfeng Shi, Takao Someya, Yanlin Song, Eleni Stavrinidou, Meng Su, Xuemei Sun, Kuniharu Takei, Xiao-Ming Tao, Benjamin C. K. Tee, Aaron Voon-Yew Thean, Tran Quang Trung, Changjin Wan, Huiliang Wang, Joseph Wang, Ming Wang, Sihong Wang, Ting Wang, Zhong Lin Wang, Paul S. Weiss, Hanqi Wen, Sheng Xu, Tailin Xu, Hongping Yan, Xuzhou Yan, Hui Yang, Le Yang, Shuaijian Yang, Lan Yin, Cunjiang Yu, Guihua Yu, Jing Yu, Shu-Hong Yu, Xinge Yu, Evgeny Zamburg, Haixia Zhang, Xiangyu Zhang, Xiaosheng Zhang, Xueji Zhang, Yihui Zhang, Yu Zhang, Siyuan Zhao, Xuanhe Zhao, Yuanjin Zheng, Yu-Qing Zheng, Zijian Zheng, Tao Zhou, Bowen Zhu, Ming Zhu, Rong Zhu, Yangzhi Zhu, Yong Zhu, Guijin Zou, and Xiaodong Chen *
柔性传感器技术路线图 - 香港
Yifei Luo, Mohammad Reza Abidian, Jong-Hyun Ahn, Deji Akinwande, Anne M. Andrews, Markus Antonietti, Zhenan Bao, Magnus Berggren, Christopher A. Berkey, Christopher John Bettinger, Jun Chen, Peng Chen, Wenlong Cheng, Xu Cheng, Seon-Jin Choi, Alex Chortos, Canan Dagdeviren, Reinhold H. Dauskardt, Chong-an Di, Michael D. Dickey, Xiangfeng Duan, Antonio Facchetti, Zhiyong Fan, Yin Fang, Jianyou Feng, Xue Feng, Huajian Gao, Wei Gao, Xiwen Gong, Chuan Fei Guo, Xiaojun Guo, Martin C. Hartel, Zihan He, John S. Ho, Youfan Hu, Qiyao Huang, Yu Huang, Fengwei Huo, Muhammad M. Hussain, Ali Javey, Unyong Jeong, Chen Jiang, Xingyu Jiang, Jiheong Kang, Daniil Karnaushenko, Ali Khademhosseini, Dae-Hyeong Kim, Il-Doo Kim, Dmitry Kireev, Lingxuan Kong, Chengkuo Lee, Nae-Eung Lee, Pooi See Lee, Tae-Woo Lee, Fengyu Li, Jinxing Li, Cuiyuan Liang, Chwee Teck Lim, Yuanjing Lin, Darren J. Lipomi, Jia Liu, Kai Liu, Nan Liu, Ren Liu, Yuxin Liu, Yuxuan Liu, Zhiyuan Liu, Zhuangjian Liu, Xian Jun Loh, Nanshu Lu, Zhisheng Lv, Shlomo Magdassi, George G. Malliaras, Naoji Matsuhisa, Arokia Nathan, Simiao Niu, Jieming Pan, Changhyun Pang, Qibing Pei, Huisheng Peng, Dianpeng Qi, Huaying Ren, John A. Rogers, Aaron Rowe, Oliver G. Schmidt, Tsuyoshi Sekitani, Dae-Gyo Seo, Guozhen Shen, Xing Sheng, Qiongfeng Shi, Takao Someya, Yanlin Song, Eleni Stavrinidou, Meng Su, Xuemei Sun, Kuniharu Takei, Xiao-Ming Tao, Benjamin C. K. Tee, Aaron Voon-Yew Thean, Tran Quang Trung, Changjin Wan, Huiliang Wang, Joseph Wang, Ming Wang, Sihong Wang, Ting Wang, Zhong Lin Wang, Paul S. Weiss, Hanqi Wen, Sheng Xu, Tailin Xu, Hongping Yan, Xuzhou Yan, Hui Yang, Le Yang, Shuaijian Yang, Lan Yin, Cunjiang Yu, Guihua Yu, Jing Yu, Shu-Hong Yu, Xinge Yu, Evgeny Zamburg, Haixia Zhang, Xiangyu Zhang, Xiaosheng Zhang, Xueji Zhang, Yihui Zhang, Yu Zhang, Siyuan Zhao, Xuanhe Zhao, Yuanjin Zheng, Yu-Qing Zheng, Zijian Zheng, Tao Zhou, Bowen Zhu, Ming Zhu, Rong Zhu, Yangzhi Zhu, Yong Zhu, Guijin Zou, and Xiaodong Chen *